Clinical Trial Update: Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study [EARLY_Phase 1]

View source ↗

Summary

A randomized, double-blind Phase 1 trial evaluating topical and local tranexamic acid to reduce bleeding during facelift surgery, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Minnesota | Conditions: Hemophilia, Hemorrhage | EARLY_Phase 1 | Status: RECRUITING